Upamostat
Upamostat (WX-671, Mesupron) is a drug which acts as an inhibitor of the serine protease enzyme urokinase. It is under development as a potential treatment agent for pancreatic cancer, acting to inhibit tumour metastasis Metastasis is a pathogenic agent's spread from an initial or primary site to a different or secondary site within the host's body; the term is typically used when referring to metastasis by a cancerous tumor. The newly pathological sites, then, .... References {{antineoplastic-drug-stub Experimental drugs Serine protease inhibitors ...
[...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]